» Articles » PMID: 39062500

PPARs in Clinical Experimental Medicine After 35 Years of Worldwide Scientific Investigations and Medical Experiments

Overview
Journal Biomolecules
Publisher MDPI
Date 2024 Jul 27
PMID 39062500
Authors
Affiliations
Soon will be listed here.
Abstract

This year marks the 35th anniversary of Professor Walter Wahli's discovery of the PPARs (Peroxisome Proliferator-Activated Receptors) family of nuclear hormone receptors. To mark the occasion, the editors of the scientific periodical Biomolecules decided to publish a special issue in his honor. This paper summarizes what is known about PPARs and shows how trends have changed and how research on PPARs has evolved. The article also highlights the importance of PPARs and what role they play in various diseases and ailments. The paper is in a mixed form; essentially it is a review article, but it has been enriched with the results of our experiments. The selection of works was subjective, as there are more than 200,000 publications in the PubMed database alone. First, all papers done on an animal model were discarded at the outset. What remained was still far too large to describe directly. Therefore, only papers that were outstanding, groundbreaking, or simply interesting were described and briefly commented on.

Citing Articles

Lipid Metabolism: An Emerging Player in Sjögren's Syndrome.

Chang K, Luo P, Guo Z, Yang L, Pu J, Han F Clin Rev Allergy Immunol. 2025; 68(1):15.

PMID: 39934534 PMC: 11813826. DOI: 10.1007/s12016-025-09023-8.

References
1.
Rudolph J, Chen L, Majumdar D, Bullock W, Burns M, Claus T . Indanylacetic acid derivatives carrying 4-thiazolyl-phenoxy tail groups, a new class of potent PPAR alpha/gamma/delta pan agonists: synthesis, structure-activity relationship, and in vivo efficacy. J Med Chem. 2007; 50(5):984-1000. DOI: 10.1021/jm061299k. View

2.
Kim G, Chen Z, Li J, Luo J, Castro-Martinez F, Wisniewski J . Gut-liver axis calibrates intestinal stem cell fitness. Cell. 2024; 187(4):914-930.e20. PMC: 10923069. DOI: 10.1016/j.cell.2024.01.001. View

3.
Housley W, Adams C, Vang A, Brocke S, Nichols F, LaCombe M . Peroxisome proliferator-activated receptor gamma is required for CD4+ T cell-mediated lymphopenia-associated autoimmunity. J Immunol. 2011; 187(8):4161-9. PMC: 3189448. DOI: 10.4049/jimmunol.1101731. View

4.
Billin A . PPAR-beta/delta agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home. Expert Opin Investig Drugs. 2008; 17(10):1465-71. DOI: 10.1517/13543784.17.10.1465. View

5.
Li X, Yin S, Li H, Yang Y, Chen X, Song B . PPAR-γ alleviates the inflammatory response in TNF-α-induced fibroblast-like synoviocytes by binding to p53 in rheumatoid arthritis. Acta Pharmacol Sin. 2022; 44(2):454-464. PMC: 9889328. DOI: 10.1038/s41401-022-00957-9. View